Lionco Pharm Grp Co Ltd
Lionco Pharmaceutical Group Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products and medical services in China. It offers chemical and prescription drugs for nutrition, antimicrobial, antiviral, digestive, cardiovascular, cerebrovascular, detoxification, anti-tumor, and other applications. The company was founded in 2003 a… Read more
Lionco Pharm Grp Co Ltd (603669) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.108x
Based on the latest financial reports, Lionco Pharm Grp Co Ltd (603669) has a cash flow conversion efficiency ratio of -0.108x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-79.09 Million) by net assets (CN¥735.30 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Lionco Pharm Grp Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Lionco Pharm Grp Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Lionco Pharm Grp Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Lionco Pharm Grp Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shenzhen New Land Co Ltd
SHE:300778
|
0.003x |
|
Hwashin
KO:010690
|
0.055x |
|
Dilip Buildcon Limited
NSE:DBL
|
-0.441x |
|
VNV Global AB
ST:VNV
|
0.007x |
|
ASRock Rack Incorporation
TW:7711
|
-0.331x |
|
Agrana Beteiligungs AG
XETRA:AGB2
|
0.020x |
|
United Malacca Bhd
KLSE:2593
|
0.088x |
|
VRG SA
WAR:VRG
|
0.016x |
Annual Cash Flow Conversion Efficiency for Lionco Pharm Grp Co Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Lionco Pharm Grp Co Ltd from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥769.76 Million | CN¥-110.89 Million | -0.144x | -254.12% |
| 2023-12-31 | CN¥931.04 Million | CN¥-37.87 Million | -0.041x | +30.41% |
| 2022-12-31 | CN¥1.14 Billion | CN¥-66.36 Million | -0.058x | -166.36% |
| 2021-12-31 | CN¥1.46 Billion | CN¥128.50 Million | 0.088x | +2.79% |
| 2020-12-31 | CN¥1.48 Billion | CN¥126.81 Million | 0.086x | -52.21% |
| 2019-12-31 | CN¥1.31 Billion | CN¥235.61 Million | 0.179x | +32.94% |
| 2018-12-31 | CN¥1.38 Billion | CN¥185.87 Million | 0.135x | -7.27% |
| 2017-12-31 | CN¥1.30 Billion | CN¥189.01 Million | 0.145x | -6.66% |
| 2016-12-31 | CN¥1.17 Billion | CN¥182.27 Million | 0.156x | +76.47% |
| 2015-12-31 | CN¥1.12 Billion | CN¥98.88 Million | 0.088x | -81.79% |
| 2014-12-31 | CN¥374.13 Million | CN¥181.50 Million | 0.485x | +5.92% |
| 2013-12-31 | CN¥351.02 Million | CN¥160.77 Million | 0.458x | -24.13% |
| 2012-12-31 | CN¥236.22 Million | CN¥142.61 Million | 0.604x | -20.99% |
| 2011-12-31 | CN¥128.55 Million | CN¥98.23 Million | 0.764x | -- |